Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer: Translating Evidence to Clinical Practice - Episode 7

Neratinib for Metastatic HER2+ Breast Cancer and Brain Metastases

, ,

Oncologists debate the use of neratinib for metastatic HER2+ breast cancer treatment in the context of the HER2CLIMB clinical trial data on tucatinib.